
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 53.50 | 53.00 | 54.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.45M | -2.64M | -0.1104 | -4.85 | 12.81M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/7/2024 17:09 | From yesterday. Another of Martlet's portfolio so good news for us. Rovco is pleased to announce the successful completion of a £30.6 million investment round, which brings a major offshore wind operator into the business alongside our current shareholders. This substantial funding will fuel international expansion, building on recent contract wins in the US, Mainland Europe, and Asian markets. The investment will be used to bolster our in-house autonomy and AI software teams, accelerating the deployment of cutting-edge technologies that are set to revolutionise the offshore wind industry. Brian Allen, CEO of Rovco, commented, "This is a thrilling chapter in Rovco's journey. Over the next 3-6 months, we anticipate making several groundbreaking announcements that will redefine our industry. This latest fundraising round is expected to be our penultimate step before taking the company public in a few years. Our sustained growth underscores the dedication of our incredibly talented teams and the unwavering support of our customers, as we continue to drive innovation and set new standards in the offshore wind sector with autonomous and AI technologies.” | ![]() loafofbread | |
26/6/2024 20:47 | They had the chance to grasp the buy back nettle at the IM but made excuses. Can't see much better investments than buying stock at 70p when it's worth more than £2.00 and increasing each month. At some point they will get a cash infusion from ProAxis sale/Glycotest deal/PDSB TO/plastics deal, etc. They have approx 90 investments already running so I have little interest in using that cash at seed level for a return in 5/10 years. Perhaps they want the share price kept low to take it private like the rest of AIM? | ![]() loafofbread | |
26/6/2024 17:17 | NSCI is always lightly traded, so there cannot be many followers or new investors. I think that there is a lack of promotion to the right audience. Despite MM has marked down the price by 1p today the spread has narrowed from 6p to only 1 p (72-73p). It would appear that MM wants sellers to sell them the stock, as they keep a tight book. In this respect, any pent up demand generated by, for example, an investment recommendation by IC or others, will raise the share price by a few pence. Anyway, as I have iterated before, unless and until the company has realised real cash in exiting one or more of its investments the share price will reach 90 p - 100 p at best in the next few months. If achieved, that is not a bad return. Years ago, I realised that investment trusts were mostly trading at a discount to their underlying assets whilst Unit Trusts were trading at a premium. This is a perception issue. NSCI is acting like an investment trust, investing in a number of companies that may generate a good return. I have no doubt in my mind that one day, we only need a blockbuster to increase the value of NSCI many folds. We live in hope. | ![]() kingston78 | |
26/6/2024 14:20 | PDSB up almost 5% early doors | ![]() blakieboy7 | |
26/6/2024 09:08 | Referring to my post 5896, POLX is on the move. The train is leaving the station. | ![]() kingston78 | |
25/6/2024 15:20 | PDSB up over 19% so far | ![]() blakieboy7 | |
25/6/2024 13:34 | It may not be appropriate for me to suggest other shares on this thread, but I would like my fellow investors to make money. I am convinced that Genedrive (GDR) and Polarean (POLX) are both about to take off. You can double your money in both of them in quick order. PLEASE DYOR. Good luck. | ![]() kingston78 | |
25/6/2024 11:32 | It is strange that MM has marked down the price by 3.5 p but narrowing down the spread to 2 p. | ![]() kingston78 | |
25/6/2024 09:15 | If Merck were to bid for PDSB at its lowest point in terms of share price (it was US$14 now less than US$3), with a likely chance of success medically, it would be a great gamble for Merck. This is the cheapest route to the drug being developed by PDSB. NSCI will therefore crystallise its investment in PDSB, hopefully at least breakeven, but get some cash in its coffer. | ![]() kingston78 | |
24/6/2024 19:13 | The spread is 5 p from 74-79 (mid 76.5). There is scope for narrowing this down if there is demand. MM wants your shares so that they can sell to others. A big spread will actually discourage sellers. Accordingly, I think that the share price will move up by 2p to 76-80. | ![]() kingston78 | |
24/6/2024 12:57 | I have tripled my investment in CAP-XX in a short space of time, and have done well despite pull back at POLX. NSCI is one of my longest and largest shareholdings. It is a hard nut to crack. It seems to be heading in the right direction now. | ![]() kingston78 | |
24/6/2024 09:39 | Like a blue monday! | ![]() blakieboy7 | |
22/6/2024 08:30 | On a one-year chart NSCI is at the top of its trading band. On a two-year chart it would go up to 90 p. Over a three year/five year chart we would see 120 p more than once, and 150 p to 180 p as a brief event. I would therefore surmise that unless the company actually has turned some of its investments into real cash, not paper profit / value the best that we can hope for in the next few months is 90 to 100 p (still under value). Perception is an illusion, but it is more powerful than reality. Or maybe you can turn it on its head to say that "reality is an illusion and it is more powerful than perception". Ultimately cash is king. | ![]() kingston78 | |
22/6/2024 08:17 | Oak bloke has done a decent write up on the Martlet portfolio (Part 1) Yet again shows the crazy value gap. | ![]() loafofbread | |
21/6/2024 17:43 | Not a bad week. | ![]() loafofbread | |
20/6/2024 08:32 | Please refer my posting 5882 on Polarean (POLX). It is going to take off. | ![]() kingston78 | |
20/6/2024 08:16 | The spread was 4 p (71-75) at the close yesterday. It was bound to go up today by at least 1 p if MM were to narrow the spread. Anyway, it has maintained a 4 p spread, but up by 1p (72-76). There is further to go until large demand pushes up the price to £1 in the next two months. There has been regular positive news update in incremental underlying value of the company's portfolio. I hope that it will not be too long before a cash exit from one of its investments. | ![]() kingston78 | |
20/6/2024 07:44 | Creeping up | ![]() blakieboy7 | |
19/6/2024 08:15 | I also have a massive holding in Genedrive (GDR) which has a recent placing at 1.5 p. It is expecting to receive excellent news from NICE by mid-July. Its price was stagnant but it is about to move upwards soon. My target 5 p. | ![]() kingston78 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions